|
Valganciclovir Impurity 4
|
纈更昔洛韋雜質(zhì)4
|
1356932-88-1
|
|
(1S,3S,4R)-Entecavir
|
（1S，3S，4R）-恩替卡韋
|
1367369-79-6
|
|
Entecavir Glucuronide
|
恩替卡韋葡糖苷酸
|
|
|
Entecavir Impurity 46
|
恩替卡韋雜質(zhì)46
|
|
|
Entecavir Impurity 7
|
恩替卡韋雜質(zhì)7
|
|
|
Vildagliptin Impurity 6
|
維格列汀雜質(zhì) 6對照品
|
2246354-69-6
|
|
Valaciclovir EP Impurity E (Valacyclovir USP Related Compound E)
|
伐昔洛韋EP雜質(zhì)E（纈昔洛韋USP相關(guān)化合物E）
|
124832-31-1
|
|
Entecavir Impurity 52
|
恩替卡韋雜質(zhì)52
|
|
|
Entecavir Impurity 57
|
恩替卡韋雜質(zhì)57
|
|
|
Entecavir Impurity 60
|
恩替卡韋雜質(zhì)60
|
|
|
Vildagliptin Impurity 19
|
維格列汀雜質(zhì)19對照品
|
1803168-09-3
|
|
Entecavir Impurity 43
|
恩替卡韋雜質(zhì)43
|
|
|
Entecavir Impurity 63
|
恩替卡韋雜質(zhì)63
|
1354695-84-3
|
|
Entecavir EP Impurity E (8-Methoxy Entecavir)
|
恩替卡韋EP雜質(zhì)E對照品
|
2203740-23-0
|
|
N-Nitroso Valaciclovir EP Impurity D (N-Nitroso Valacyclovir USP Related Compound D)
|
N-亞硝基伐昔洛韋EP雜質(zhì)D（N-亞硝基纈昔洛韋USP相關(guān)化合物D）
|
|
|
Vildagliptin Impurity 56
|
維格列汀雜質(zhì) 56對照品
|
19179-12-5
|
|
Entecavir Impurity 39
|
恩替卡韋雜質(zhì)39
|
|
|
Entecavir Impurity 38
|
恩替卡韋雜質(zhì)38
|
|
|
Entecavir Impurity 42
|
恩替卡韋雜質(zhì)42
|
1661867-19-1
|
|
Entecavir Impurity 20
|
恩替卡韋雜質(zhì)20
|
|
|
Entecavir Impurity 41
|
恩替卡韋雜質(zhì)41
|
1345339-53-8
|
|
Valaciclovir EP Impurity C
|
伐昔洛韋EP雜質(zhì)C
|
1346747-65-6
|
|
N-Formyl Vildagliptin Impurity 26
|
N-甲酰維格列汀雜質(zhì)26對照品
|
|
|
Entecavir Impurity 19
|
恩替卡韋雜質(zhì)19
|
|
|
Entecavir Impurity 11
|
恩替卡韋雜質(zhì)11
|
|
|
(R)-Vildagliptin Impurity 61 Tosylate
|
(R)-維格列汀雜質(zhì) 61 甲苯磺酸鹽對照品
|
739363-75-8
|
|
Entecavir Impurity 6 (ent-Entecavir-di-O-benzyl Ether)
|
恩替卡韋雜質(zhì)6（恩特卡韋二-O-芐基醚）
|
1354695-82-1
|
|
(1R,3R,4R)-Entecavir HCl
|
（1R，3R，4R）-鹽酸恩替卡韋
|
|
|
Entecavir Impurity 32
|
恩替卡韋雜質(zhì)32
|
1415118-53-4
|
|
Entecavir EP Impurity A (1'-epi-Entecavir)
|
恩替卡韋EP雜質(zhì)A對照品（1'-依替卡韋）
|
1367369-78-5
|
|
Vildagliptin Impurity 63
|
維格列汀雜質(zhì)63對照品
|
63808-36-6
|
|
Cyclo(L-Pro-L-Pro)
|
維格列汀雜質(zhì)ZY7對照品
|
19943-27-2
|
|
Vildagliptin Impurity 53 HCl
|
維格列汀雜質(zhì) 53鹽酸鹽對照品
|
2165668-69-7
|
|
Entecavir Impurity 37
|
恩替卡韋雜質(zhì)37
|
1907700-40-6
|
|
Vildagliptin Impurity 51
|
維格列汀雜質(zhì) 51對照品
|
5001-18-3
|
|
DBU
|
DBU對照品
|
6674-22-2
|
|
Entecavir Impurity 8
|
恩替卡韋雜質(zhì)8
|
|
|
Entecavir Impurity 61
|
恩替卡韋雜質(zhì)61
|
|
|
Entecavir Impurity 9
|
恩替卡韋雜質(zhì)9
|
|
|
Entecavir EP Impurity F
|
恩替卡韋EP雜質(zhì)F
|
649761-24-0
|
|
Vildagliptin Impurity 67
|
維格列汀雜質(zhì)67對照品
|
741657-02-3
|
|
Entecavir Impurity A
|
恩替卡韋雜質(zhì)A
|
1984788-96-6
|
|
Vildagliptin Impurity 39 HCl
|
維格列汀雜質(zhì)39鹽酸鹽對照品
|
|
|
Oseltamivir EP Impurity E phosphate
|
奧司他韋EP雜質(zhì)E磷酸鹽
|
208720-71-2
|
|
Entecavir Impurity 33
|
恩替卡韋雜質(zhì)33
|
1415118-52-3
|
|
(1R, 3S, 4S)-Entecavir (Impurity D)
|
（1R，3S，4S）-恩替卡韋（雜質(zhì)D）
|
1333204-94-6
|
|
Vildagliptin Impurity 55
|
維格列汀雜質(zhì) 55對照品
|
948574-56-9
|
|
(S)-Vildagliptin Impurity 61
|
(S)-維格列汀雜質(zhì)61對照品
|
204387-53-1
|
|
Entecavir Impurity 2
|
恩替卡韋雜質(zhì)2
|
142217-79-6
|
|
Vildagliptin Impurity 36
|
維格列汀雜質(zhì)36對照品
|
|
|
Entecavir Impurity 58
|
恩替卡韋雜質(zhì)58
|
1354715-30-2
|
|
Vildagliptin Impurity 13
|
維格列汀雜質(zhì) 13對照品
|
|
|
Vildagliptin Impurity 8
|
維格列汀雜質(zhì) 8對照品
|
20297-37-4
|
|
Vildagliptin Impurity 33
|
維格列汀雜質(zhì)33對照品
|
|
|
Entecavir Impurity 28
|
恩替卡韋雜質(zhì)28
|
110567-21-0
|
|
Ganciclovir Impurity 17
|
更昔洛韋雜質(zhì)17
|
|
|
Vildagliptin Impurity 9
|
維格列汀雜質(zhì) 9對照品
|
|
|
Entecavir Impurity 48
|
恩替卡韋雜質(zhì)48
|
110567-22-1
|
|
Valaciclovir EP Impurity D (Valacyclovir USP Related Compound D)
|
伐昔洛韋EP雜質(zhì)D（纈昔洛韋USP相關(guān)化合物D）
|
1346747-69-0
|
|
Entecavir Impurity 12
|
恩替卡韋雜質(zhì)12
|
|
|
Hydroxy Vildagliptin
|
羥基維格列汀對照品
|
|
|
ent-Entecavir
|
恩替卡韋異構(gòu)體對照品
|
188399-46-4
|
|
Vildagliptin Impurity 58
|
維格列汀雜質(zhì)58對照品
|
|
|
Entecavir EP Impurity C (8-Hydroxy Entecavir)
|
恩替卡韋EP雜質(zhì)C（8-羥基恩替卡維爾）
|
|
|
(S)-Vildagliptin Impurity 61 Tosylate
|
(S)-維格列汀雜質(zhì)61甲苯磺酸鹽對照品
|
204387-54-2
|
|
Ganciclovir Impurity 15
|
更昔洛韋雜質(zhì)15
|
96480-02-3
|
|
Vildagliptin Impurity ZY1
|
維格列汀雜質(zhì)ZY1對照品
|
|
|
Entecavir Impurity 40
|
恩替卡韋雜質(zhì)40
|
873298-16-9
|
|
Vildagliptin Impurity 52 HCl
|
維格列汀雜質(zhì) 52 鹽酸鹽對照品
|
913980-23-1
|
|
Entecavir Impurity 21
|
恩替卡韋雜質(zhì)21
|
84868-56-4
|
|
Ganciclovir Impurity 11
|
更昔洛韋雜質(zhì)11
|
89419-27-2
|
|
Entecavir Impurity 65
|
恩替卡韋雜質(zhì)65
|
|
|
Entecavir N-Oxide
|
恩替卡韋N-氧化物
|
|
|
N-Nitroso Vildagliptin Related Compound 1 (S-Isomer)
|
N-亞硝基維格列汀相關(guān)化合物1（S-異構(gòu)體）對照品
|
|
|
Valaciclovir EP Impurity N
|
伐昔洛韋EP雜質(zhì)N
|
2519847-26-6
|
|
Vildagliptin Impurity ZY9
|
維格列汀雜質(zhì)ZY9對照品
|
|
|
Entecavir Impurity 17
|
恩替卡韋雜質(zhì)17
|
|
|
Ganciclovir Impurity 16
|
更昔洛韋雜質(zhì)16
|
96480-03-4
|
|
Entecavir Impurity 66
|
恩替卡韋雜質(zhì)66
|
156422-39-8
|
|
Entecavir Impurity 59
|
恩替卡韋雜質(zhì)59
|
117641-39-1
|
|
Entecavir Impurity 30
|
恩替卡韋雜質(zhì)30
|
1354695-79-6
|
|
Vildagliptin Impurity 64
|
維格列汀雜質(zhì)64對照品
|
620601-77-6
|
|
Ganciclovir Impurity 9
|
更昔洛韋雜質(zhì)9
|
10548-25-1
|
|
Entecavir Impurity 27
|
恩替卡韋雜質(zhì)27
|
|
|
Vildagliptin Impurity 37 HCl
|
維格列汀雜質(zhì)37鹽酸鹽對照品
|
|
|
Entecavir EP Impurity B HCl
|
恩替卡韋EP雜質(zhì)B鹽酸
|
1367369-77-4
|
|
Vildagliptin Impurity 17 (Mixture of Diastereomers)
|
維格列汀雜質(zhì) 17（非對映體混合物）對照品
|
1846606-32-3
|
|
N-Hydroxy Vildagliptin
|
N-羥基維格列汀對照品
|
|
|
Ganciclovir Impurity 12
|
更昔洛韋雜質(zhì)12
|
105681-83-2
|
|
(R)-Vildagliptin Related Compound 2 HCl
|
(R)-維格列汀相關(guān)化合物2鹽酸鹽對照品
|
|
|
Valaciclovir EP Impurity D Enantiomer (Valacyclovir USP Related Compound D Enantiomer)
|
伐昔洛韋EP雜質(zhì)D對映異構(gòu)體（伐昔洛維USP相關(guān)化合物D對映體）
|
1799279-90-5
|
|
Vildagliptin Impurity 11
|
維格列汀雜質(zhì) 11對照品
|
|
|
Entecavir Impurity 18
|
恩替卡韋雜質(zhì)18
|
|
|
Vildagliptin Impurity 50
|
維格列汀雜質(zhì) 50對照品
|
|
|
Vildagliptin Impurity ZY8
|
維格列汀雜質(zhì)ZY8對照品
|
|
|
N-Nitroso (S)-Vildagliptin Impurity 61
|
N-亞硝基(S)-維格列汀雜質(zhì)61對照品
|
|
|
D-Valacyclovir HCl
|
D-伐昔洛韋鹽酸鹽
|
124832-28-6
|
|
Vildagliptin Impurity 49
|
維格列汀雜質(zhì) 49對照品
|
|
|
Ganciclovir Impurity 18
|
更昔洛韋雜質(zhì)18
|
|
|
Entecavir-15N-13C2
|
恩替卡韋-15N-13C2
|
|